13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC
SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-12, with 82 holding rows worth $741,600,759.
- Accession
- 0001420506-25-003142
- Filer
- CIK 1816307
- Filed
- 2025-11-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 82 entries on the cover page, a total value of $741,600,759 stated on the cover page (in dollars after the unit check, H1), rows summing to $741,600,759 with VALUE read as dollars as filed, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSilverArc Capital, LLC 028-20993
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 539,704 | $45,820,870 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 369,996 | $37,365,896 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 844,633 | $36,800,660 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 372,300 | $32,196,504 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 1,577,283 | $31,466,796 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 643,636 | $30,559,837 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 206,648 | $29,759,378 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 674,966 | $26,559,912 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 455,000 | $26,558,350 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 638,346 | $25,712,577 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL | 91307C952 | PUT | 59,900 | $25,110,679 | dollars as filed | put |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,948,808 | $23,385,696 | dollars as filed | |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 220,902 | $21,153,576 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 10,600,000 | $16,854,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,363,378 | $16,605,944 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 1,000,000 | $16,370,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D908 | CALL | 528,200 | $15,888,256 | dollars as filed | call |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 4,779,082 | $12,568,986 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 815,075 | $11,704,477 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 211,000 | $11,596,560 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 314,339 | $11,322,491 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 80,419 | $11,265,094 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 53,554 | $10,647,071 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 2,833,988 | $9,918,958 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 700,000 | $9,513,000 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,042,757 | $9,207,544 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 720,922 | $9,162,919 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 933,541 | $9,139,366 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 348,922 | $9,026,612 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 233,920 | $8,711,181 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 235,791 | $8,094,705 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 463,708 | $7,134,148 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 203,946 | $6,057,196 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 259,509 | $5,600,204 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 180,513 | $5,415,390 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 588,789 | $5,387,419 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 457,414 | $5,296,854 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 994,754 | $5,252,301 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 778,611 | $5,169,977 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q901 | CALL | 360,000 | $5,169,600 | dollars as filed | call |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 694,942 | $5,149,520 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 3,311,165 | $4,867,413 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 183,903 | $4,588,380 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 88,686 | $4,381,088 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 2,715,786 | $4,318,100 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 1,897,383 | $4,212,190 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 2,782,923 | $4,146,555 | dollars as filed | |
| AARDVARK THERAPEUTICS INC | 002942100 | COM | 306,912 | $4,078,861 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 250,606 | $3,957,069 | dollars as filed | |
| BENITEC BIOPHARMA INC | 08205P209 | COMMON STOCK | 276,267 | $3,876,026 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 88,910 | $3,452,375 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 141,238 | $3,425,022 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 230,837 | $3,287,119 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 108,801 | $3,199,837 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 720,452 | $3,119,557 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 80,000 | $3,033,600 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,368,075 | $2,982,404 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 51,210 | $2,714,130 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 2,850,987 | $2,537,949 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 203,386 | $2,186,400 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 50,000 | $2,082,500 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 653,594 | $1,960,782 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 166,161 | $1,952,392 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 100,000 | $1,265,000 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 70,000 | $1,105,300 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B959 | COM NEW | 144,700 | $1,043,287 | dollars as filed | put |
| MERSANA THERAPEUTICS INC | 59045L205 | COM | 133,636 | $1,037,015 | dollars as filed | |
| RADIOPHARM THERANOSTICS LTD | 75041J101 | SPONSORED ADS | 187,406 | $1,034,481 | dollars as filed | |
| ATYR PHARMA INC | 002120952 | COM NEW | 1,250,000 | $901,250 | dollars as filed | put |
| IMMUNOVANT INC | 45258J102 | COM | 50,000 | $806,000 | dollars as filed | |
| ARCTURUS THERAPEUTICS HLDGS | 03969T959 | COM | 42,000 | $774,060 | dollars as filed | put |
| SYNDAX PHARMACEUTICALS INC | 87164F905 | COM | 50,000 | $769,500 | dollars as filed | call |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D958 | COM | 25,000 | $752,000 | dollars as filed | put |
| MOONLAKE IMMUNOTHERAPEUTICS | 61559X904 | CLASS A ORD | 65,000 | $466,050 | dollars as filed | call |
| MODULAR MED INC | 60785L207 | COM NEW | 639,531 | $447,544 | dollars as filed | |
| BIODESIX INC COM | 09075X207 | Stock | 49,607 | $374,533 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 15,000 | $262,500 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 10,675 | $218,517 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 30,000 | $215,100 | dollars as filed | |
| ARCTURUS THERAPEUTICS HLDGS | 03969T109 | COM | 3,445 | $63,491 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 365 | $20,769 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 104,828 | $4,109 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-003142 | this filing | 2025-11-12 | acceptance time not in the bulk data set |